Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells.

Srivastava A, Amreddy N, Babu A, Panneerselvam J, Mehta M, Muralidharan R, Chen A, Zhao YD, Razaq M, Riedinger N, Kim H, Liu S, Wu S, Abdel-Mageed AB, Munshi A, Ramesh R.

Sci Rep. 2016 Dec 12;6:38541. doi: 10.1038/srep38541.

2.

Microbial Sulfate Reduction Potential in Coal-Bearing Sediments Down to ~2.5 km below the Seafloor off Shimokita Peninsula, Japan.

Glombitza C, Adhikari RR, Riedinger N, Gilhooly WP 3rd, Hinrichs KU, Inagaki F.

Front Microbiol. 2016 Oct 5;7:1576. eCollection 2016.

3.

DEEP BIOSPHERE. Exploring deep microbial life in coal-bearing sediment down to ~2.5 km below the ocean floor.

Inagaki F, Hinrichs KU, Kubo Y, Bowles MW, Heuer VB, Hong WL, Hoshino T, Ijiri A, Imachi H, Ito M, Kaneko M, Lever MA, Lin YS, Methé BA, Morita S, Morono Y, Tanikawa W, Bihan M, Bowden SA, Elvert M, Glombitza C, Gross D, Harrington GJ, Hori T, Li K, Limmer D, Liu CH, Murayama M, Ohkouchi N, Ono S, Park YS, Phillips SC, Prieto-Mollar X, Purkey M, Riedinger N, Sanada Y, Sauvage J, Snyder G, Susilawati R, Takano Y, Tasumi E, Terada T, Tomaru H, Trembath-Reichert E, Wang DT, Yamada Y.

Science. 2015 Jul 24;349(6246):420-4. doi: 10.1126/science.aaa6882. Epub 2015 Jul 23.

4.

An inorganic geochemical argument for coupled anaerobic oxidation of methane and iron reduction in marine sediments.

Riedinger N, Formolo MJ, Lyons TW, Henkel S, Beck A, Kasten S.

Geobiology. 2014 Mar;12(2):172-81. doi: 10.1111/gbi.12077. Epub 2014 Jan 27.

PMID:
24460948
5.

Characterization of Metabolically Active Bacterial Populations in Subseafloor Nankai Trough Sediments above, within, and below the Sulfate-Methane Transition Zone.

Mills HJ, Reese BK, Shepard AK, Riedinger N, Dowd SE, Morono Y, Inagaki F.

Front Microbiol. 2012 Apr 3;3:113. doi: 10.3389/fmicb.2012.00113. eCollection 2012.

6.

Medical care of obese children and adolescents. APV: a standardised multicentre documentation derived to study initial presentation and cardiovascular risk factors in patients transferred to specialised treatment institutions.

Reinehr T, Wabitsch M, Andler W, Beyer P, Böttner A, Chen-Stute A, Fromme C, Hampel O, Keller KM, Kilian U, Kolbe H, Lob-Corzilius T, Marg W, Mayer H, Mohnike K, Oepen J, Povel C, Richter B, Riedinger N, Schauerte G, Schmahlfeldt G, Siegfried W, Smuda P, Stachow R, van Egmond-Fröhlich A, Weiten J, Wiegand S, Witte S, Zindel V, Holl RW; APV Study Group.

Eur J Pediatr. 2004 Jun;163(6):308-12.

PMID:
15346912

Supplemental Content

Loading ...
Support Center